Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371135 · ClinicalTrials.gov registry record
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
A clinical trial of Lynch Syndrome and Hereditary Colonic Polyposis Syndromes, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 77
- Enrollment target
- 1
- Study location
NCT02371135 is a study of Lynch Syndrome and Hereditary Colonic Polyposis Syndromes that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 77 participants, below the 2,313-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02371135, a study of Lynch Syndrome and Hereditary Colonic Polyposis Syndromes, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the role bacteria that normally live in the colon may play in colorectal cancer risk, in addition to the hereditary risk to colorectal cancer. The investigators will collect stool specimens as well as additional colon biopsy specimens during the patient's scheduled colonoscopy procedure. The investigators will also collect a questionnaire about diet and lifestyle. The samples will be used to study the impact of diet on naturally-occurring oral and gut bacteria and their influences on human health including risk of cancer.
Conditions Studied
Interventions
- GENETIC colonic biopsies
- GENETIC questionnaires
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2015-02 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371135
The ClinicalTrials.gov registry entry for NCT02371135 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,313-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (97% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lynch Syndrome appearing as the primary indexed condition, and to 2 interventions - of which colonic biopsies is the first listed.
NCT02371135 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02371135 about?
NCT02371135 is a clinical study titled "Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes". The purpose of this study is to understand the role bacteria that normally live in the colon may play in colorectal cancer risk, in addition to the hereditary risk to colorectal cancer. The investigators will collect stool specimens as well as additional colon biopsy specimens during the patient's s...
What is the current status of trial NCT02371135?
This trial is currently active not recruiting. The enrollment target is 77 participants. The study started on 2015-02. Estimated completion is 2027-02.
What conditions does trial NCT02371135 study?
This clinical trial studies the following conditions: Lynch Syndrome, Hereditary Colonic Polyposis Syndromes.
What interventions are being tested in trial NCT02371135?
The interventions under investigation include: colonic biopsies (GENETIC), questionnaires (GENETIC).
Who is sponsoring clinical trial NCT02371135?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02371135 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lynch Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Cancer of the Pancreas Screening-5 CAPS5)Study
RECRUITING · Phase 3
-
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
RECRUITING
-
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
RECRUITING
-
Lynch Syndrome Integrative Epidemiology and Genetics
RECRUITING
-
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
RECRUITING · Phase 2
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.